Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples
A legfontosabb adatok
- Ki végzi
- Assistance Publique - Hôpitaux de Paris
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 18 fő, tervezett
- Kezdés
- 2025. ápr. 30.
- Várható befejezés
- 2027. ápr. 30.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Biological sampling
- A regiszteradat frissítve
- 2025. május 6.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for children aged 3 to 12 with Down syndrome (trisomy 21), with or without gum inflammation. It also takes comparison children without Down syndrome. Blood and mouth samples are collected.
- Életkor
- 3 to 12 years
- Nem
- All
- A betegség stádiuma
- Children with trisomy 21 who have gum inflammation, or healthy gums with no history of periodontitis (gum disease). Comparison children have psychomotor delay or no known general illness, with or without gum inflammation.
- Korábbi kezelés
- No antibiotics given to prevent or treat infection, and no anti-inflammatory treatment, in the 3 months before joining.
- Biomarker vagy leletérték
- Children in the trisomy 21 group must have a genetic diagnosis.
A részvétel fő kizáró okai
- Antibiotics or anti-inflammatory treatment in the last 3 months
- Taking part in another interventional study, or in an exclusion period
- Covered by AME (French state medical aid), or not covered by social security
- Reasons the child cannot use MEOPA (laughing gas mix), such as needing pure oxygen, raised pressure in the skull, collapsed lung or untreated vitamin B12 deficiency
- Parents or guardians who do not read and understand French well enough
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- Common to all groups:
- Age: 3 to 12
- Patient affiliated to a social security program, beneficiary not covered by the AME
- Legal representatives who speak and understand French well enough to be able to read and understand the study information
- Legal representatives giving written consent for their child's participation in the study; Specific:; Case Group:
- Trisomy 21 patient with gingival inflammation (subgroup 1)
- Trisomy 21 patient with healthy gingiva on intact periodontium with no history of periodontitis (subgroup 2); Control Group: child meeting one of these criteria:
- Patient with psychomotor retardation with no known repercussions on the orofacial sphere or immunity, presenting gingival inflammation (subgroup 1)
- Patients with psychomotor retardation and no known repercussions on orofacial health or immunity, presenting gingival health on intact periodontium with no history of gingival inflammation (subgroup 2)
- Patients with no known general pathology and gingival inflammation (subgroup 3)
- Patients with no known general pathology and healthy gingiva on intact periodontium with no history of gingival inflammation (subgroup 4)
Ki nem vehet részt
- Patient having received antibiotic prophylaxis, antibiotic therapy or anti-inflammatory treatment in the 3 months prior to inclusion
- Patients with a contraindication to the use of MEOPA:; Patients requiring pure oxygen ventilation; Intracranial hypertension; Unevaluated head trauma; New-onset, unexplained neurological abnormalities; Pneumothorax; Emphysema bubbles; Gas embolism; Diving accident; Abdominal gas distension, occlusion; Patient recently treated with ophthalmic gas (SF6, C3F8, C2F6); Known, unsubstituted vitamin B12 deficiency; Specific to Trisomy 21 group:
- Common to all groups:
- Patient included in another interventional research protocol or in a period of exclusion
- Patient on AME
- Patient with no genetic diagnosis
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 3 és 12 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Franciaország.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Since 2018, the Chicago Classification of Periodontal Diseases and Conditions, has listed Down syndrome (DS)/trisomy 21 (T21) as a systemic disease with periodontal implications. Numerous studies report an increased prevalence and severity of periodontitis in DS/T21 individuals under the age of 35. Approximately 35% of adolescents with DS show early signs of alveolar bone loss. However, very few studies have examined the role of immune deficiency in DS/T21 patients in the pathogenesis of periodontitis. Indeed, periodontitis induced by bacterial plaque is virtually non-existent in the paediatric population, leaving the field to systemically-induced periodontitis.
A teljes eredeti leírásKevesebb
The investigators hypothesize that specific neutrophil phenotypes in DS/T21 patients are key to explaining the rapid progression to periodontitis.
Investigator's primary objective is to characterize the different oral and blood neutrophil subtypes in DS/T21 children with gingival inflammation.
Investigator's secondary objective is to assess the involvement of different neutrophil subtypes in early periodontitis in children with DS/T21.
A vizsgálat csoportja
- Child patient consulting the serviceA vizsgált kezelés
* Trisomy 21 patient with gingival inflammation (subgroup 1) * Trisomy 21 patient with healthy gingiva on intact periodontium with no history of periodontitis (subgroup 2) * Patient with psychomotor retardation with no known repercussions on the orofacial sphere or immunity, presenting gingival inflammation (subgroup 1) * Patients with psychomotor retardation and no known repercussions on orofacial health or immunity, presenting gingival health on intact periodontium with no history of gingival inflammation (subgroup 2). * Patients with no known general pathology and gingival inflammation (subgroup 3) * Patients with no known general pathology and healthy gingiva on intact periodontium with no history of gingival inflammation (subgroup 4)
Kezelés: Biological sampling
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Study of Neutrophils During Gingival Inflammation in Children With Down Syndrome/Trisomy 21
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT05970965: ki vehet részt
- A regiszteradat frissítve
- 2025. május 6.